Lowe Brockenbrough & Co’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.57M Sell
18,095
-979
-5% -$93.8K 0.08% 142
2025
Q4
$1.83M Sell
19,074
-17
-0.1% -$1.65K 0.09% 130
2025
Q3
$1.82M Buy
19,091
+22
+0.1% +$2.02K 0.09% 129
2025
Q2
$1.66M Sell
19,069
-48
-0.3% -$4.07K 0.09% 132
2025
Q1
$1.73M Sell
19,117
-74
-0.4% -$6.62K 0.11% 127
2024
Q4
$1.55M Sell
19,191
-1,207
-6% -$104K 0.1% 135
2024
Q3
$1.85M Sell
20,398
-793
-4% -$66.7K 0.12% 129
2024
Q2
$1.68M Sell
21,191
-2,413
-10% -$198K 0.11% 133
2024
Q1
$2.07M Sell
23,604
-1,176
-5% -$100K 0.14% 125
2023
Q4
$2.06M Sell
24,780
-711
-3% -$54.2K 0.16% 119
2023
Q3
$2.02M Sell
25,491
-783
-3% -$65.5K 0.16% 123
2023
Q2
$2.33M Sell
26,274
-230
-0.9% -$19.8K 0.18% 115
2023
Q1
$2.15M Sell
26,504
-500
-2% -$40.8K 0.17% 117
2022
Q4
$2.12M Sell
27,004
-1,205
-4% -$97.7K 0.18% 117
2022
Q3
$2.3M Buy
28,209
+1,687
+6% +$152K 0.22% 106
2022
Q2
$2.4M Sell
26,522
-1,213
-4% -$123K 0.21% 110
2022
Q1
$3.1M Sell
27,735
-517
-2% -$54.6K 0.23% 105
2021
Q4
$2.94M Sell
28,252
-687
-2% -$79.6K 0.21% 101
2021
Q3
$3.65M Buy
28,939
+1,731
+6% +$224K 0.28% 93
2021
Q2
$3.38M Sell
27,208
-130
-0.5% -$16.3K 0.3% 82
2021
Q1
$3.23M Buy
27,338
+224
+0.8% +$26.3K 0.31% 83
2020
Q4
$3.18M Sell
27,114
-595
-2% -$65.5K 0.34% 81
2020
Q3
$2.88M Sell
27,709
-227
-0.8% -$22.8K 0.36% 78
2020
Q2
$2.56M Sell
27,936
-410
-1% -$39.3K 0.34% 78
2020
Q1
$2.56M Buy
28,346
+521
+2% +$55.4K 0.42% 70
2019
Q4
$3.16M Sell
27,825
-36
-0.1% -$3.95K 0.39% 74
2019
Q3
$3.03M Sell
27,861
-864
-3% -$90.1K 0.41% 75
2019
Q2
$2.8M Buy
28,725
+145
+0.5% +$13.2K 0.38% 77
2019
Q1
$2.6M Buy
28,580
+567
+2% +$50.7K 0.36% 82
2018
Q4
$2.55M Sell
28,013
-115
-0.4% -$10.7K 0.42% 72
2018
Q3
$2.77M Buy
28,128
+80
+0.3% +$7.4K 0.39% 74
2018
Q2
$2.4M Buy
28,048
+820
+3% +$68.5K 0.35% 83
2018
Q1
$2.18M Buy
27,228
+180
+0.7% +$14.8K 0.32% 90
2017
Q4
$2.18M Buy
27,048
+95
+0.4% +$7.61K 0.31% 87
2017
Q3
$2.1M Buy
26,953
+60
+0.2% +$4.98K 0.32% 84
2017
Q2
$2.39M Sell
26,893
-83
-0.3% -$7K 0.38% 78
2017
Q1
$2.17M Buy
26,976
+2,388
+10% +$187K 0.35% 80
2016
Q4
$1.75M Buy
24,588
+1,180
+5% +$92.7K 0.29% 88
2016
Q3
$2.02M Hold
23,408
0.35% 79
2016
Q2
$2.03M Sell
23,408
-425
-2% -$34.4K 0.35% 79
2016
Q1
$1.79M Sell
23,833
-200
-0.8% -$15.1K 0.31% 86
2015
Q4
$1.85M Sell
24,033
-100
-0.4% -$7.53K 0.32% 88
2015
Q3
$1.61M Sell
24,133
-1,405
-6% -$103K 0.28% 95
2015
Q2
$1.89M Sell
25,538
-740
-3% -$56.5K 0.3% 88
2015
Q1
$2.05M Buy
26,278
+593
+2% +$44.9K 0.32% 87
2014
Q4
$1.85M Sell
25,685
-300
-1% -$20.8K 0.29% 88
2014
Q3
$1.61M Sell
25,985
-150
-0.6% -$9.54K 0.26% 92
2014
Q2
$1.67M Sell
26,135
-250
-0.9% -$15.2K 0.27% 90
2014
Q1
$1.62M Hold
26,385
0.27% 87
2013
Q4
$1.51M Hold
26,385
0.25% 89
2013
Q3
$1.41M Sell
26,385
-165
-0.6% -$8.88K 0.26% 86
2013
Q2
$1.37M Buy
+26,550
New +$1.31M 0.25% 91

Other funds holding MDT

Lowe Brockenbrough & Co's MDT Position: Q1 2026 in Review

Lowe Brockenbrough & Co reduced its Medtronic (MDT) stake by 5.1% in Q1 2026, selling an estimated $93.8K and leaving 18,095 shares worth $1.57M. The position accounts for 0.08% of the portfolio, ranked #142.

Lowe Brockenbrough & Co first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.65M in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Lowe Brockenbrough & Co held 18,095 shares of Medtronic worth $1.57M as of Q1 2026.
  • Lowe Brockenbrough & Co sold 979 Medtronic shares in Q1 2026, an estimated $93.8K.
  • Medtronic made up 0.08% of Lowe Brockenbrough & Co's portfolio in Q1 2026, its #142 holding.
  • Lowe Brockenbrough & Co first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Lowe Brockenbrough & Co's Medtronic position peaked at $3.65M in Q3 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Lowe Brockenbrough & Co's 13F filing for Q1 2026, filed 7 May 2026.